CISATRACURIUM BESYLATE, created in 2000 (United States), from 1125 sister brands and 17478 competing brands. CISATRACURIUM BESYLATE is a brand of Pfizer Inc, listed on the stock exchange of New York. The sector of CISATRACURIUM BESYLATE is Drug Manufacturers.